[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@polycle Dr.R
Dr.R posts on X about $bcab, $cytx, $gmab, $adct the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Month XXX -XX%
- X Year XXXXX +76%
Mentions: X #
- X Month X -XX%
- X Year X +75%
Followers: XXX #
- X Month XXX +1.50%
- X Year XXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social topic influence $bcab #1, $cytx, $gmab, $adct, not in
Top Social Posts #
Top posts by engagements in the last XX hours
"@BioValues $BCAB The competitors stop developing in the early stages of AXL or ROR12 or Epcam. BP are also making every effort to develop ROR1-ADC but ROR2 has a high level of normal tissue so no one is entering because of its high development difficulty. This is the same for Epcam"
X Link @polycle 2025-10-14T23:31Z XXX followers, XX engagements
"@BioValues $BCAB ADC companies in the U.S. even if they're not in Korea right now. You can see that they're significantly undervalued compared to $CYTX $GMAB $ADCT etc. I think yesterday's drop is very deliberate and price manipulation"
X Link @polycle 2025-10-14T23:29Z XXX followers, XXX engagements